149 related articles for article (PubMed ID: 19003589)
1. Congenic expression of tissue inhibitor of metalloproteinase in Dahl-salt sensitive hypertensive rats is associated with reduced LV hypertrophy.
Rodriguez WE; Tyagi N; Deng AY; Adeagbo A; Joshua IG; Tyagi SC
Arch Physiol Biochem; 2008 Dec; 114(5):340-8. PubMed ID: 19003589
[TBL] [Abstract][Full Text] [Related]
2. Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats.
Iwanaga Y; Aoyama T; Kihara Y; Onozawa Y; Yoneda T; Sasayama S
J Am Coll Cardiol; 2002 Apr; 39(8):1384-91. PubMed ID: 11955860
[TBL] [Abstract][Full Text] [Related]
3. Estrogen effects on MMP-13 and MMP-14 regulation of left ventricular mass in Dahl salt-induced hypertension.
Dai Q; Lin J; Craig T; Chou YM; Hinojosa-Laborde C; Lindsey ML
Gend Med; 2008 Mar; 5(1):74-85. PubMed ID: 18420168
[TBL] [Abstract][Full Text] [Related]
4. Distinct genomic replacements from Lewis correct diastolic dysfunction, attenuate hypertension, and reduce left ventricular hypertrophy in Dahl salt-sensitive rats.
Deng AY; Nattel S; Shi Y; L'heureux N; Cardin S; Ménard A; Roy J; Tardif JC
J Hypertens; 2008 Oct; 26(10):1935-43. PubMed ID: 18806617
[TBL] [Abstract][Full Text] [Related]
5. Regression of left ventricular hypertrophy after surgical therapy for aortic stenosis is associated with changes in extracellular matrix gene expression.
Walther T; Schubert A; Falk V; Binner C; Kanev A; Bleiziffer S; Walther C; Doll N; Autschbach R; Mohr FW
Circulation; 2001 Sep; 104(12 Suppl 1):I54-8. PubMed ID: 11568030
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
Ahmed SH; Clark LL; Pennington WR; Webb CS; Bonnema DD; Leonardi AH; McClure CD; Spinale FG; Zile MR
Circulation; 2006 May; 113(17):2089-96. PubMed ID: 16636176
[TBL] [Abstract][Full Text] [Related]
7. Amlodipine and Atorvastatin Improved Hypertensive Cardiac Remodeling through Regulation of MMPs/TIMPs in SHR Rats.
Lu J; Hao J; Du H; Xiao B; Li Y; Yang X; Cui W
Cell Physiol Biochem; 2016; 39(1):47-60. PubMed ID: 27322513
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of MMP-9 attenuates hypertensive cerebrovascular dysfunction in Dahl salt-sensitive rats.
Kalani A; Pushpakumar SB; Vacek JC; Tyagi SC; Tyagi N
Mol Cell Biochem; 2016 Feb; 413(1-2):25-35. PubMed ID: 26800984
[TBL] [Abstract][Full Text] [Related]
9. MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition.
Li H; Simon H; Bocan TM; Peterson JT
Cardiovasc Res; 2000 May; 46(2):298-306. PubMed ID: 10773234
[TBL] [Abstract][Full Text] [Related]
10. [Ventricular remodeling and matrix metalloproteinase-1 and its tissue inhibitor of metalloproteinase-1 in serum in third trimester of pregnant women with cardiac disease.].
Zhang ZL; Lin JH; Tao RQ
Zhonghua Fu Chan Ke Za Zhi; 2009 Oct; 44(10):731-5. PubMed ID: 20078957
[TBL] [Abstract][Full Text] [Related]
11. Estrogen improves TIMP-MMP balance and collagen distribution in volume-overloaded hearts of ovariectomized females.
Voloshenyuk TG; Gardner JD
Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R683-93. PubMed ID: 20504902
[TBL] [Abstract][Full Text] [Related]
12. Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats.
Iwanaga Y; Kihara Y; Hasegawa K; Inagaki K; Yoneda T; Kaburagi S; Araki M; Sasayama S
Circulation; 1998 Nov; 98(19):2065-73. PubMed ID: 9808606
[TBL] [Abstract][Full Text] [Related]
13. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
Peterson JT; Li H; Dillon L; Bryant JW
Cardiovasc Res; 2000 May; 46(2):307-15. PubMed ID: 10773235
[TBL] [Abstract][Full Text] [Related]
14. Curcumin, an Inhibitor of p300-HAT Activity, Suppresses the Development of Hypertension-Induced Left Ventricular Hypertrophy with Preserved Ejection Fraction in Dahl Rats.
Sunagawa Y; Funamoto M; Shimizu K; Shimizu S; Sari N; Katanasaka Y; Miyazaki Y; Kakeya H; Hasegawa K; Morimoto T
Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444769
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal Antibody to Marinobufagenin Downregulates TGFβ Profibrotic Signaling in Left Ventricle and Kidney and Reduces Tissue Remodeling in Salt-Sensitive Hypertension.
Zhang Y; Wei W; Shilova V; Petrashevskaya NN; Zernetkina VI; Grigorova YN; Marshall CA; Fenner RC; Lehrmann E; Wood WH; Becker KG; Lakatta EG; Bagrov AY; Fedorova OV
J Am Heart Assoc; 2019 Oct; 8(20):e012138. PubMed ID: 31576777
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone, a thiazolidinedione derivative, attenuates left ventricular hypertrophy and fibrosis in salt-sensitive hypertension.
Nakamoto M; Ohya Y; Shinzato T; Mano R; Yamazato M; Sakima A; Takishita S
Hypertens Res; 2008 Feb; 31(2):353-61. PubMed ID: 18360056
[TBL] [Abstract][Full Text] [Related]
17. Signal pathways involved in reverse remodeling of the hypertrophic rat heart after pressure unloading.
Xu R; Lin F; Zhang S; Chen X; Hu S; Zheng Z
Int J Cardiol; 2010 Sep; 143(3):414-23. PubMed ID: 19631998
[TBL] [Abstract][Full Text] [Related]
18. Teneligliptin Prevents Cardiomyocyte Hypertrophy, Fibrosis, and Development of Hypertensive Heart Failure in Dahl Salt-Sensitive Rats.
Yamamoto M; Ishizu T; Seo Y; Suto Y; Sai S; Xu D; Murakoshi N; Kimura T; Kawakami Y; Aonuma K
J Card Fail; 2018 Jan; 24(1):53-60. PubMed ID: 28888840
[TBL] [Abstract][Full Text] [Related]
19. TIMP-2 mutant decreases MMP-2 activity and augments pressure overload induced LV dysfunction and heart failure.
Givvimani S; Kundu S; Narayanan N; Armaghan F; Qipshidze N; Pushpakumar S; Vacek TP; Tyagi SC
Arch Physiol Biochem; 2013 May; 119(2):65-74. PubMed ID: 23398532
[TBL] [Abstract][Full Text] [Related]
20. Antifibrotic response of cardiac fibroblasts in hypertensive hearts through enhanced TIMP-1 expression by basic fibroblast growth factor.
Kinoshita T; Ishikawa Y; Arita M; Akishima-Fukasawa Y; Fujita K; Inomata N; Suzuki T; Namiki A; Mikami T; Ikeda T; Yamazaki J; Ishii T; Akasaka Y
Cardiovasc Pathol; 2014; 23(2):92-100. PubMed ID: 24322055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
